KIT and neoplasm: Furthermore, unlike normal cells, c-Kit-depleted tumor cells had phospho-LYN levels similar to those of control cells (Figure S2D) and treatment of Brca1 tumor cells with the ACK2 c-KIT blocking antibody did not alter LYN phosphorylation status (Figure S2E; contrast with Figure 1I).